Pre-analytical characterization of cell-free DNA to enable liquid biopsy for solid tumors

PGDx elio^TM plasma focus assesses cell-free DNA (cfDNA) to enable non-invasive genomic profiling with next-generation sequencing. This study characterized a range of pre-analytic factors including cfDNA fraction and yield across 293 clinical plasma samples.